https://www.selleckchem.com/products/brd0539.html
83, 95% CI 1.46-5.49; for XAB2, P = 0.008, HR = 2.38, 95% CI 1.23-4.63) and platinum resistance (for HELQ, P less then 0.001; for XAB2, P = 0.006). In the validation cohort, the combination of HELQ and XAB2 (AUC = 0.863) showed the highest AUC. The expression levels of HELQ (RR 5.7, 95% CI 1.7-19.2) and XAB2 (RR 3.2, 95% CI 0.9-10.8) in ascites tumor cells were positively correlated to the risk of platinum resistance. In summary, we revealed that the expression levels of HELQ and XAB2 are candidate predictors for primary chemotherapy re
Like
Comment
Share
